In recent years, fragment-primarily based drug discovery has developed in popularity as an efficient process to discover direct molecules. Label-free detection technologies, for example thermal shift assays and SPR, are perfect for fragment screening due to their superior potential and sensitivity to evaluate lower affinity binding. product or ser… Read More